Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Rong Zhou sold 5,000 shares of the business’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $51.79, for a total value of $258,950.00. Following the completion of the sale, the executive vice president now directly owns 96,888 shares […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Rong Zhou sold 5,000 shares of the company’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $51.79, for a total value of $258,950.00. Following the sale, the executive vice president now owns 96,888 shares of the company’s stock, […]
Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) had its price target boosted by Piper Sandler from $43.00 to $55.00 in a research report sent to investors on Thursday, The Fly reports. Separately, StockNews.com lowered Amphastar Pharmaceuticals from a strong-buy rating to a buy rating in a research note on Tuesday, June 13th. Amphastar Pharmaceuticals Trading Up […]
Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Rating) and Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation. Volatility and Risk Crinetics Pharmaceuticals has a beta of 0.94, […]